DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4Dr. Reddy's Laboratories
02 1Olpha
03 2Adamed Pharma
04 1Alhavi Pharma
05 2Alkem Laboratories
06 2Annora Pharma
07 1Aurobindo Pharma Limited
08 40Boehringer Ingelheim GmbH
09 6Farmaprojects S.A.U
10 3Grupo Azevedos
11 4Intas Pharmaceuticals
12 1InvaGen Pharmaceuticals Inc
13 2Kinapse
14 2MSN Laboratories
15 1Mahban Group
16 4Pharmaline
17 3Pluviaendo
18 3Prinston
19 3Sun Pharmaceutical Industries Limited
20 4Sunshine Lake Pharma
21 2Tecnimede
22 3Varian Pharmed
23 3Viatris
24 4XYZ Pharma
25 4Zentiva
26 4Zydus Pharmaceuticals
01 6Antic-calc Tablet, Film Coated
02 3FILM COATED PILL
03 14Film Coated Tablet
04 4Film Coated Tablet
05 3Filmtabl
06 7Filmtable
07 1Linagliptin 5Mg 28 Combined Oral Use
08 1Metformin+Linagliptin+2,51,000 Mg 56 Combined Oral Use
09 1Metformin+Linagliptin+2,5850 Mg 56 Combined Oral Use
10 4Oral Solid Dosage Form
11 4TABLET
12 6TABLET, EXTENDED RELEASE;ORAL
13 4TABLET; ORAL
14 33TABLET;ORAL
15 11Tablet
16 2Tablets
17 1Tablets
18 2tablet
19 2Blank
01 4DISCN
02 1Dossier Readiness: Q1 2025
03 2Generic
04 4Lead Market Dossiers- Filed
05 4Prescription
06 17RX
07 77Blank
01 3EMPAGLIFLOZIN AND LINAGLIPTIN
02 6EMPAGLIFLOZIN; LINAGLIPTIN
03 2GLYXAMBI
04 2Glyxambi
05 6JENTADUETO
06 2JENTADUETO XR
07 14Jentadueto
08 5LINAGLIPTIN
09 1LINAGLIPTIN 5
10 14LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
11 3LINAGLIPTIN; METFORMIN HYDROCHLORIDE
12 1Melijent
13 1TRADJENTA
14 1TRAJENTA
15 4TRIJARDY XR
16 8Trajenta
17 36Blank
01 2Australia
02 4Canada
03 4Czech Republic
04 8India
05 5Iran
06 3Italy
07 1Latvia
08 4Lebanon
09 6Norway
10 2Poland
11 5Portugal
12 6Spain
13 3Sweden
14 10Switzerland
15 3Turkey
16 43USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness: Q1 2025
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness: Q1 2025
Registration Country : Latvia
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 850MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 1G
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info :
Registration Country : USA
Brand Name : LINAGLIPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 208415
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TRADJENTA
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2011-05-02
Application Number : 201280
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLYXAMBI
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG;5MG
Packaging :
Approval Date : 2015-01-30
Application Number : 206073
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLYXAMBI
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG;5MG
Packaging :
Approval Date : 2015-01-30
Application Number : 206073
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2016-05-27
Application Number : 208026
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG;1GM
Packaging :
Approval Date : 2016-05-27
Application Number : 208026
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LINAGLIPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2024-09-03
Application Number : 208423
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LINAGLIPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2021-08-31
Application Number : 208335
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2021-08-30
Application Number : 208336
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date : 2021-08-30
Application Number : 208336
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2021-08-30
Application Number : 208336
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date :
Application Number : 208430
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date :
Application Number : 208430
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date :
Application Number : 208430
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG; 500MG
Packaging :
Approval Date :
Application Number : 208427
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG; 850MG
Packaging :
Approval Date :
Application Number : 208427
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG; 1G
Packaging :
Approval Date :
Application Number : 208427
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : LINAGLIPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 208428
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LINAGLIPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2023-03-30
Application Number : 208448
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2023-03-30
Application Number : 208449
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date : 2023-03-30
Application Number : 208449
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2023-03-30
Application Number : 208449
Regulatory Info : DISCN
Registration Country : USA
